Genetics - Global Neurology Academy

33-45 of 45

Duchenne Muscular Dystrophy Management: Analyzing Current Approaches
Duchenne Muscular Dystrophy Management: Analyzing Current Approaches
NeuroFrontiers
Duchenne Muscular Dystrophy Management: Analyzing Current Approaches
Nancy Kuntz, MD
- Nancy Kuntz, MD
Diagnosing Duchenne Muscular Dystrophy: Recognizing Signs and Reducing Delays
Diagnosing Duchenne Muscular Dystrophy: Recognizing Signs and Reducing Delays
NeuroFrontiers
Diagnosing Duchenne Muscular Dystrophy: Recognizing Signs and Reducing Delays
Nancy Kuntz, MD
- Nancy Kuntz, MD
Genetics and Schizophrenia: Key Ethical Considerations
Genetics and Schizophrenia: Key Ethical Considerations
NeuroFrontiers
Genetics and Schizophrenia: Key Ethical Considerations
Aaron Besterman, MD
- Aaron Besterman, MD
Developments in Duchenne Muscular Dystrophy Care: Examining the Options
Developments in Duchenne Muscular Dystrophy Care: Examining the Options
NeuroFrontiers
Developments in Duchenne Muscular Dystrophy Care: Examining the Options
Challenges in DMD: Understanding the Height Factor
Challenges in DMD: Understanding the Height Factor
NeuroFrontiers
Challenges in DMD: Understanding the Height Factor
Continuum of Care: Managing DMD in Pediatric and Adult Patients
Continuum of Care: Managing DMD in Pediatric and Adult Patients
NeuroFrontiers
Continuum of Care: Managing DMD in Pediatric and Adult Patients
John Brandsema, MD
- John Brandsema, MD
Comprehensive Care: Navigating Neurobehavioral Issues in DMD Patients
Comprehensive Care: Navigating Neurobehavioral Issues in DMD Patients
NeuroFrontiers
Comprehensive Care: Navigating Neurobehavioral Issues in DMD Patients
John Brandsema, MD
- John Brandsema, MD
Advances in DMD Care: Evaluating a Gene Therapy’s Efficacy and Safety
Advances in DMD Care: Evaluating a Gene Therapy’s Efficacy and Safety
NeuroFrontiers
Advances in DMD Care: Evaluating a Gene Therapy’s Efficacy and Safety
Charles Turck, PharmD, BCPS, BCCCP; John Brandsema, MD
- Charles Turck, PharmD, BCPS, BCCCP
- John Brandsema, MD
Toxic Short RNAs May Cause Neuronal Cell Death in Alzheimer’s Disease
Toxic Short RNAs May Cause Neuronal Cell Death in Alzheimer’s Disease
NeuroFrontiers
Toxic Short RNAs May Cause Neuronal Cell Death in Alzheimer’s Disease
Andrew Wilner, MD, FACP, FAAN; Marcus E. Peter, PhD
- Andrew Wilner, MD, FACP, FAAN
- Marcus E. Peter, PhD
Uncovering Disease Progression in Multiple Sclerosis
Uncovering Disease Progression in Multiple Sclerosis
NeuroFrontiers
Uncovering Disease Progression in Multiple Sclerosis
Sergio Baranzini, PhD
- Sergio Baranzini, PhD
Epigenetics in the Environment: An Exploration of Genetics & Chronic Health Conditions
Epigenetics in the Environment: An Exploration of Genetics & Chronic Health Conditions
Clinician's Roundtable
Epigenetics in the Environment: An Exploration of Genetics & Chronic Health Conditions
Hector O. Chapa, MD, FACOG; Julio M. Jimenez
- Hector O. Chapa, MD, FACOG
- Julio M. Jimenez
Expert Debate: The Ethics of Consumer Genetic Testing
Expert Debate: The Ethics of Consumer Genetic Testing
Clinician's Roundtable
Expert Debate: The Ethics of Consumer Genetic Testing
David Weisman, MD; John Khoury, MD
- David Weisman, MD
- John Khoury, MD
Research on Genetic Traits of ADHD
Research on Genetic Traits of ADHD
Focus on Neurology and Psychiatry
Research on Genetic Traits of ADHD
Vatsal Thakkar, MD; Randy Blakely, PhD
- Vatsal Thakkar, MD
- Randy Blakely, PhD

Previous
1
2
3
Next

3/3